首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   861篇
  免费   51篇
  国内免费   11篇
耳鼻咽喉   3篇
儿科学   78篇
妇产科学   5篇
基础医学   97篇
口腔科学   12篇
临床医学   99篇
内科学   156篇
皮肤病学   3篇
神经病学   46篇
特种医学   157篇
外科学   103篇
综合类   9篇
预防医学   49篇
眼科学   7篇
药学   52篇
中国医学   2篇
肿瘤学   45篇
  2023年   2篇
  2022年   3篇
  2021年   10篇
  2020年   5篇
  2019年   5篇
  2018年   7篇
  2017年   7篇
  2016年   13篇
  2015年   16篇
  2014年   20篇
  2013年   28篇
  2012年   29篇
  2011年   37篇
  2010年   20篇
  2009年   24篇
  2008年   27篇
  2007年   23篇
  2006年   27篇
  2005年   27篇
  2004年   30篇
  2003年   24篇
  2002年   22篇
  2001年   13篇
  2000年   15篇
  1999年   14篇
  1998年   39篇
  1997年   63篇
  1996年   44篇
  1995年   37篇
  1994年   37篇
  1993年   27篇
  1992年   19篇
  1991年   13篇
  1990年   8篇
  1989年   21篇
  1988年   24篇
  1987年   20篇
  1986年   25篇
  1985年   21篇
  1984年   10篇
  1983年   6篇
  1982年   12篇
  1981年   7篇
  1980年   8篇
  1978年   9篇
  1977年   13篇
  1976年   4篇
  1975年   6篇
  1970年   1篇
  1969年   1篇
排序方式: 共有923条查询结果,搜索用时 688 毫秒
901.
Newman  PJ; Allen  RW; Kahn  RA; Kunicki  TJ 《Blood》1985,65(1):227-232
A murine monoclonal antibody specific for glycoprotein (GP)IIIa was prepared by immunization with a GPIIb- and GPIIIa-enriched Triton X-114 extract of platelet membranes. This antibody, designated AP-3, was shown by indirect immunoprecipitation to react solely with GPIIIa derived from either P1A1-positive or -negative individuals. The epitope on GPIIIa recognized by AP-3 is expressed on dissociated GPIIIa as well as on Ca+2-dependent complexes of GPIIb and GPIIIa, as shown by crossed immunoelectrophoresis in the presence or absence of EDTA. A previously described monoclonal antibody specific for the GPIIb/IIIa complex (AP- 2) inhibited platelet aggregation induced by ADP, thrombin, collagen, or arachidonic acid (Pidard et al, J Biol Chem 258:12582-12586, 1983). In contrast, AP-3 had no effect on aggregation induced by any of these reagents, a finding similar to that previously reported for the GPIIb- specific monoclonal antibody, Tab (McEver et al, J Clin Invest 66:1311- 1318, 1980). At saturation, 40,200 AP-3 molecules were bound per platelet, a value similar to that obtained for AP-2 or Tab. Thus, data derived using AP-3 indicate that significant amounts of free GPIIIa are not present, thereby supporting the hypothesis that GPIIb and GPIIIa exist complexed in a 1:1 stoichiometry in the plasma membrane of intact, nonactivated platelets.  相似文献   
902.
The regulatory function of recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) on granulocyte production in vivo was evaluated in an autologous bone marrow transplantation model using rhesus monkeys. Monkeys were exposed to 9.0 Gy total body irradiation and then transplanted with 5.0 x 10(7) low-density bone marrow cells/kg. Alzet miniosmotic pumps were subcutaneously implanted to deliver rhGM-CSF at a rate of 50,400 U/kg/d. Minipumps, containing either rhGM-CSF or saline, were implanted between zero and five days after transplantation for seven days. Kinetic recoveries of peripheral blood cells after either saline or rhGM-CSF treatment were compared. Treatment with rhGM-CSF accelerated the recovery of neutrophils. Neutrophils in rhGM-CSF-treated animals recovered to 80% (3.4 x 10(3)/mm3) pre-irradiation control levels by day 20, in comparison with only 33% (0.9 x 10(3)/mm3) recovery for saline control monkeys. In addition, the recovery of neutrophils was enhanced over that of the controls, reaching 140% v 70% on day 30. Another prominent feature of rhGM-CSF-treated monkeys was the accelerated recovery of platelets, reaching near 50% normal levels by day 24 in comparison with 20% of normal levels for controls. The infusion of rhGM-CSF was shown to be an effective regulator of early hematopoietic regeneration, leading to the accelerated recovery of both neutrophils and platelets and then providing a consistent sustained increase of neutrophils even in the absence of rhGM-CSF.  相似文献   
903.
In the present study, we describe how a nonstoichiometric ratio of the isomers of 8-hydroxy-2-(di-n-propylamino)tetralin (DPAT) produce a broad-spectrum of antiemetic effects in cats and shrews. Determination of the receptor profile of the isomers and testing them separately in cats revealed superior antiemetic effects but severe defensive behavior with the R isomer compared with the S isomer. Differing ratios yielded the best results with the 1:8 (RS) ratio producing a drug more potent than DPAT and with negligible defensive behavior side effects. Studies with selective 5-HT1D ligands led to the conclusion that this site contributes antiemetic efficacy but is not related to defensive behavior, which is most likely a consequence of 5-HT7 receptor activation. ETI-385 was effective in preventing emetic responses to provocative motion, drugs acting at the chemical trigger zone and cisplatin in both cats and shrews. The results support a clinical trial of this drug for antiemetic effects.  相似文献   
904.
In the current investigation, we examined the changes in performance, task-related thoughts (TRT), and task-unrelated thoughts (TUT) over four sessions of a modified sustained attention to response task (SART). Eighteen participants completed a clockwise manual selection SART (Head and Helton in Conscious Cogn 22:913–919, 2013) and a conscious thought questionnaire once a week for four weeks. Response times and errors of commission oscillated over sessions in line with a motor strategy interpretation of the SART. As participants became faster in the task, they made more commission errors. The conscious thought questionnaire failed to show a relationship between errors of commission and TRT and TUT on the SART at either a between-subject or within-subject level of analysis. Commission errors in the SART may be better measures of executive motor control and response strategy than perceptual decoupling.  相似文献   
905.
Objective.?To determine the opinion among three groups of women (sub-fertile women, fertile women and female medical students), concerning the use of ovarian reserve tests to determine the chance of an assisted reproductive techniques' (ART) induced pregnancy or a spontaneous pregnancy.

Design.?Prospective study using questionnaires in three groups of women: patients visiting the out patient infertility clinic at the Academic Medical Centre Groningen, women who had delivered at least two children and female medical students.

Results.?The response rate varied from 63% (female medical students) to 56% (fertile women with children) and 48% (sub-fertile women). The greater part of women of all three groups found it was up to the women themselves to decide whether or not to start fertility treatment, even though the ovarian reserve test indicated little chance of success. 71% of the sub-fertile women stated that any chance justified fertility treatment. None of the three groups of women were very enthusiastic about the use of these tests for family planning.

Conclusions.?Based on results of ovarian reserve tests women could decide not to partake of a - generally demanding - fertility treatment. The outcome of the study, however, does not support this: even low chances of success are found acceptable. The ability to determine the individual ovarian reserve makes this test also a suitable device for family planning. The discussion whether these new possibilities will be useful for reproductive science will greatly depend on women's attitude towards this issue.  相似文献   
906.

Background Context

It remains unclear whether cervical laminoplasty (LP) offers advantages over cervical laminectomy and fusion (LF) in patients undergoing posterior decompression for degenerative cervical myelopathy (DCM).

Purpose

The objective of this study is to compare outcomes of LP and LF.

Study Design/Setting

This is a multicenter international prospective cohort study.

Patient Sample

A total of 266 surgically treated symptomatic DCM patients undergoing cervical decompression using LP (N=100) or LF (N=166) were included.

Outcome Measures

The outcome measures were the modified Japanese Orthopaedic Association score (mJOA), Nurick grade, Neck Disability Index (NDI), Short-Form 36v2 (SF36v2), length of hospital stay, length of stay in the intensive care unit, treatment complications, and reoperations.

Methods

Differences in outcomes between the LP and LF groups were analyzed by analysis of variance and analysis of covariance. The dependent variable in all analyses was the change score between baseline and 24-month follow-up, and the independent variable was surgical procedure (LP or LF). In the analysis of covariance, outcomes were compared between cohorts while adjusting for gender, age, smoking, number of operative levels, duration of symptoms, geographic region, and baseline scores.

Results

There were no differences in age, gender, smoking status, number of operated levels, and baseline Nurick, NDI, and SF36v2 scores between the LP and LF groups. Preoperative mJOA was lower in the LP compared with the LF group (11.52±2.77 and 12.30±2.85, respectively, p=.0297). Patients in both groups showed significant improvements in mJOA, Nurick grade, NDI, and SF36v2 physical and mental health component scores 24 months after surgery (p<.0001). At 24 months, mJOA scores improved by 3.49 (95% confidence interval [CI]: 2.84, 4.13) in the LP group compared with 2.39 (95% CI: 1.91, 2.86) in the LF group (p=.0069). Nurick grades improved by 1.57 (95% CI: 1.23, 1.90) in the LP group and 1.18 (95% CI: 0.92, 1.44) in the LF group (p=.0770). There were no differences between the groups with respect to NDI and SF36v2 outcomes. After adjustment for preoperative characteristics, surgical factors and geographic region, the differences in mJOA between surgical groups were no longer significant. The rate of treatment-related complications in the LF group was 28.31% compared with 21.00% in the LP group (p=.1079).

Conclusions

Both LP and LF are effective at improving clinical disease severity, functional status, and quality of life in patients with DCM. In an unadjusted analysis, patients treated with LP achieved greater improvements on the mJOA at 24-month follow-up than those who received LF; however, these differences were insignificant following adjustment for relevant confounders.  相似文献   
907.
This study investigated the incidence of injury in sub-elite Rugby League players before and after the introduction of the limited interchange rule. The incidence of injury was prospectively studied in one sub-elite Rugby League club over three competitive seasons. Two seasons were played under the unlimited interchange rule, while the third season was played under the limited interchange rule. Players participated in 91 matches under the unlimited interchange rule and 44 matches under the limited interchange rule. Injury was defined as any pain, disability or injury that occurred as a result of a competition game that caused the player to miss a subsequent game. The relative risk (RR) of injury significantly decreased (RR = 0.70 [0.65 to 0.75], P<0.05) following the introduction of the limited interchange rule, with the incidence of injury decreasing from 72.5 (58.2 to 86.8) per 1000 playing hr under the unlimited interchange rule to 51.0 (33.8 to 68.1) per 1000 playing hr under the limited interchange rule. The risk of sustaining thigh and calf injuries (RR= 0.27 [0.12 to 0.59], P < 0.05), muscular strains (RR= 0.23 10.17 to 0.31]., P<0.05), and high intensity running injuries (RR= 0.16 [0.04 to 0.691, P<0.05) was significantly reduced following the introduction of the limited interchange rule. These findings demonstrate that the risk of injury in sub-elite Rugby League players is significantly reduced following the introduction of the limited interchange rule. The reduced injury risk may reflect a fatigue-induced reduction in match speed and impact forces associated with physical collisions and tackles.  相似文献   
908.
909.
As the use of electronic health records increases, it becomes necessary to address their global impact on nurses' productivity in hospitals. A retrospective cross-sectional study was conducted to explore the impact of electronic health records on nurses' productivity and to examine whether the impacts are moderated through case-mix index or adjusted patient-days. Two sources of data were linked and analyzed for years 2007 and 2008: the American Hospital Association survey and the Centers for Medicare & Medicaid Services data. Almost two-thirds of the respondent hospitals in both years (63.9% in 2007 and 68.4% in 2008) had a high electronic health record index (≥5). Hospitals with higher penetration of electronic health records had more RNs employed (coefficient=0.234, P=.002) compared with hospitals with low penetration of electronic health records, even when controlling for adjusted patient-day volumes. This difference decreased for hospitals with higher case-mix index values. The study findings fail to suggest any financial savings or superior productivity in nurses due to usage of electronic health records.  相似文献   
910.
This article is the second part of a two-part review in which we explore the biomechanics of the sensor-tissue interface as an important aspect of continuous glucose sensor biocompatibility. Part I, featured in this issue of Journal of Diabetes Science and Technology, describes a theoretical framework of how biomechanical factors such as motion and pressure (typically micromotion and micropressure) affect tissue physiology around a sensor and in turn, impact sensor performance. Here in Part II, a literature review is presented that summarizes examples of motion or pressure affecting sensor performance. Data are presented that show how both acute and chronic forces can impact continuous glucose monitor signals. Also presented are potential strategies for countering the ill effects of motion and pressure on glucose sensors. Improved engineering and optimized chemical biocompatibility have advanced sensor design and function, but we believe that mechanical biocompatibility, a rarely considered factor, must also be optimized in order to achieve an accurate, long-term, implantable sensor.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号